HUGEL

2026-04-01

Hugel to enter ECM-based injectable market with aesthetic portfolio expansion

Hugel secures the domestic sales rights for ECM-based injectable CellREDM, planning collaboration with Hans Biomed l The company aims to create synergies with its botulinum toxin and dermal filler products as a new growth engine

2026-02-11

Hugel reports record-high annual results for 2025

Net sales and operating profit reached record highs of KRW425.1 billion and KRW201.6 billion, up 14% and 21.3% on-year, respectively

January 16, 2026

Hugel accelerates global value creation with U.S.-led growth strategy

President and Global CEO Carrie Strom outlines mid-term growth strategy including global vision, U.S. channel strategy, and portfolio expansion l Hugel targets KRW900 billion in total net sales and 30% of sales from U.S. by 2028

November 4, 2025

Hugel posts KRW105.9 billion in Q3 net sales on continued global growth

Operating profit and net income reached KRW47.4 billion and KRW38 billion, respectively; the company marked two consecutive quarters surpassing KRW100 billion in net sales

October 13, 2025

Hugel Inc. appoints Carrie Strom as Chief Executive Officer

Carrie Strom is a 25-year pharmaceutical and aesthetics industry leader who previously served as Global President of Allergan Aesthetics

September 15, 2025

Hugel hosts global H.E.L.F. symposium, marking 15 years of botulinum toxin Letybo

It highlights K-beauty values and global medical aesthetic trends l The event welcomes around 220 professionals from more than 25 countries

September 8, 2025

Hugel strengthens Brazil presence with Letybo launch and new partner Derma Dream

The two companies hosted brand pre-launch events for toxin product Letybo in the first week of September to strengthen networks with local healthcare professionals

August 11, 2025

Hugel launches botulinum toxin Letybo in Malaysia

The company strengthens brand experience for local medical professionals through academic events and hands-on workshops

August 6, 2025

Hugel posts record first-half net sales exceeding KRW200 billion in H1 2025

The net sales and operating profit for Q2 hit KRW110.3 billion and KRW56.7 billion, up 15.5% and 33.6% on-year, respectively

May 13, 2025

Hugel officially launches its botulinum toxin Botulax in UAE

The company renews its momentum in the Middle East with the event where 180 dermatologists and plastic surgeons attended

News

點擊查看飛速發展的HUGEL最新消息。